User profiles for Alexander J. Trotter
Alexander J TrotterQuadram Institute Bioscience Verified email at nbi.ac.uk Cited by 9379 |
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
…, J Giandhari, J Li, J Yasuda, JQ Mends, J Kiconco… - Science, 2021 - science.org
The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
…, A Sayed, A Kazeem, A Balde, A Christoffels, AJ Trotter… - Science, 2022 - science.org
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …
in Africa over the past year has led to a major increase in the number of sequences that have …
Rapid increase in Omicron infections in England during December 2021: REACT-1 study
The unprecedented rise in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections during December 2021 was concurrent with rapid spread of the Omicron variant in …
infections during December 2021 was concurrent with rapid spread of the Omicron variant in …
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
BACKGROUND The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection continues to drive rates of illness and hospitalizations despite high levels …
infection continues to drive rates of illness and hospitalizations despite high levels …
Twin peaks: the Omicron SARS-CoV-2 BA. 1 and BA. 2 epidemics in England
Rapid transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant has led to record-breaking incidence rates around the world. The Real-time …
Omicron variant has led to record-breaking incidence rates around the world. The Real-time …
REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with delta variant in England during May to …
Background The prevalence of SARS-CoV-2 infection continues to drive rates of illness and
hospitalisations despite high levels of vaccination, with the proportion of cases caused by …
hospitalisations despite high levels of vaccination, with the proportion of cases caused by …
[HTML][HTML] SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
Background England has experienced a third wave of the COVID-19 epidemic since the end
of May, 2021, coinciding with the rapid spread of the delta (B.1.617.2) variant, despite high …
of May, 2021, coinciding with the rapid spread of the delta (B.1.617.2) variant, despite high …
Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance
Highlights • Rapid diagnostics are essential in the fight against antimicrobial resistance. •
BioFire® FilmArray® panels can identify pathogen resistance genes in 1 hour. • Accelerate …
BioFire® FilmArray® panels can identify pathogen resistance genes in 1 hour. • Accelerate …
[HTML][HTML] CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes
…, L Meadows, A Bell, AV Gutierrez, AJ Trotter… - Genome medicine, 2021 - Springer
We present CoronaHiT, a platform and throughput flexible method for sequencing SARS-CoV-2
genomes (≤ 96 on MinION or > 96 on Illumina NextSeq) depending on changing …
genomes (≤ 96 on MinION or > 96 on Illumina NextSeq) depending on changing …
REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant
Background England entered a third national lockdown from 6 January 2021 due to the
COVID-19 pandemic. Despite a successful vaccine rollout during the first half of 2021, cases and …
COVID-19 pandemic. Despite a successful vaccine rollout during the first half of 2021, cases and …